Drug repurposing patent documents vs peer review: patent information comes more than 600 days earlier on average

This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific info…


COVID-19 Investigational Drugs and Supply Chain

After hearing about shortages of investigational drugs for COVID-19, I’ve pulled the relevant information to help drug manufacturers, suppliers, distributors, and pharmacies to track and source drugs with potential efficacy against COVID-19. CAUTION: This material is for informational purposes only. Listing on this page does not imply that these compounds have been evaluated by any […]


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!